Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valtteri V Aho

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Eye Research|September 11, 2002
Group IIA phospholipase A2 content of basal, nonstimulated and reflex tearsValtteri V Aho, Timo J Nevalainen, K Matti Saari
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 24, 2002
Group IIA phospholipase A2 content of tears in patients with keratoconjunctivitis siccaValtteri V Aho, Timo J Nevalainen, K Matti Saari
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 27, 2005
Bactericidal/permeability-increasing protein in lacrimal gland and in tears of healthy subjectsHeikki Peuravuori, Valtteri V Aho, Heikki J Aho, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 28, 2003
Diurnal variation in group IIa phospholipase A2 content in tears of contact lens wearers and normal controlsValtteri V Aho, Ville Paavilainen, Timo J Nevalainen, et al.
Journal of Cataract and Refractive Surgery|December 13, 2003
Group IIA phospholipase A(2) content in tears of patients having photorefractive keratectomyValtteri V Aho, Juha M Holopainen, Timo Tervo, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|December 14, 2004
Group IIA phospholipase A2 content of tears in patients with atopic blepharoconjunctivitisHeikki Peuravuori, Osmo Kari, Sirje Peltonen, et al.
Acta Ophthalmologica Scandinavica|July 21, 2005
Group IIA phospholipase A(2) concentration of tears in patients with ocular rosaceaOsmo Kari, Valtteri V Aho, Sirje Peltonen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 19, 2019
Oral levosimendan in amyotrophic lateral sclerosis: a phase II multicentre, randomised, double-blind, placebo-controlled trialAmmar Al-Chalabi, Pamela Shaw, P Nigel Leigh, et al.
The Lancet. Neurology|September 18, 2021
Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trialMerit Cudkowicz, Angela Genge, Nicholas Maragakis, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Eye Research|September 11, 2002
Group IIA phospholipase A2 content of basal, nonstimulated and reflex tearsValtteri V Aho, Timo J Nevalainen, K Matti Saari
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 24, 2002
Group IIA phospholipase A2 content of tears in patients with keratoconjunctivitis siccaValtteri V Aho, Timo J Nevalainen, K Matti Saari
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 27, 2005
Bactericidal/permeability-increasing protein in lacrimal gland and in tears of healthy subjectsHeikki Peuravuori, Valtteri V Aho, Heikki J Aho, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 28, 2003
Diurnal variation in group IIa phospholipase A2 content in tears of contact lens wearers and normal controlsValtteri V Aho, Ville Paavilainen, Timo J Nevalainen, et al.
Journal of Cataract and Refractive Surgery|December 13, 2003
Group IIA phospholipase A(2) content in tears of patients having photorefractive keratectomyValtteri V Aho, Juha M Holopainen, Timo Tervo, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|December 14, 2004
Group IIA phospholipase A2 content of tears in patients with atopic blepharoconjunctivitisHeikki Peuravuori, Osmo Kari, Sirje Peltonen, et al.
Acta Ophthalmologica Scandinavica|July 21, 2005
Group IIA phospholipase A(2) concentration of tears in patients with ocular rosaceaOsmo Kari, Valtteri V Aho, Sirje Peltonen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 19, 2019
Oral levosimendan in amyotrophic lateral sclerosis: a phase II multicentre, randomised, double-blind, placebo-controlled trialAmmar Al-Chalabi, Pamela Shaw, P Nigel Leigh, et al.
The Lancet. Neurology|September 18, 2021
Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trialMerit Cudkowicz, Angela Genge, Nicholas Maragakis, et al.
Pageof 1